rs67486287

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000415950.5(SCN1B):​c.749G>A​(p.Arg250Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000361 in 1,550,376 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 6 hom. )

Consequence

SCN1B
ENST00000415950.5 missense

Scores

1
1
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.409

Publications

31 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056346953).
BP6
Variant 19-35034040-G-A is Benign according to our data. Variant chr19-35034040-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 139000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00023 (35/152124) while in subpopulation SAS AF = 0.00355 (17/4786). AF 95% confidence interval is 0.00226. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AD,Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1BNM_001037.5 linkc.448+301G>A intron_variant Intron 3 of 5 ENST00000262631.11 NP_001028.1
SCN1BNM_199037.5 linkc.749G>A p.Arg250Lys missense_variant Exon 3 of 3 NP_950238.1
SCN1BNM_001321605.2 linkc.349+301G>A intron_variant Intron 3 of 5 NP_001308534.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1BENST00000262631.11 linkc.448+301G>A intron_variant Intron 3 of 5 1 NM_001037.5 ENSP00000262631.3

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152006
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00355
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000795
AC:
123
AN:
154732
AF XY:
0.00121
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000131
Gnomad NFE exome
AF:
0.0000665
Gnomad OTH exome
AF:
0.000230
GnomAD4 exome
AF:
0.000375
AC:
524
AN:
1398252
Hom.:
6
Cov.:
31
AF XY:
0.000526
AC XY:
363
AN XY:
689732
show subpopulations
African (AFR)
AF:
0.0000317
AC:
1
AN:
31574
American (AMR)
AF:
0.00
AC:
0
AN:
35706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25172
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.00496
AC:
393
AN:
79214
European-Finnish (FIN)
AF:
0.000304
AC:
15
AN:
49284
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5698
European-Non Finnish (NFE)
AF:
0.0000854
AC:
92
AN:
1077914
Other (OTH)
AF:
0.000276
AC:
16
AN:
57956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.424
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152124
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41542
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00355
AC:
17
AN:
4786
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67962
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000400
Hom.:
298
ExAC
AF:
0.00128
AC:
51

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 04, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Brugada syndrome 5 Benign:1
Dec 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN1B: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
11
DANN
Benign
0.95
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.30
T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.0056
T;T
MetaSVM
Benign
-0.70
T
PhyloP100
0.41
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.040
N;.
REVEL
Benign
0.066
Sift
Pathogenic
0.0
D;.
Polyphen
0.0010
B;.
Vest4
0.13
MVP
0.84
MPC
0.81
ClinPred
0.047
T
GERP RS
1.8
gMVP
0.22
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67486287; hg19: chr19-35524944; API